Multiple myeloma: open trials in Taiwan

19 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT07222761
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Kaohsiung Medical University Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · Taipei Municipal Wan Fang Hospital, Taipei · National Taiwan University Hospital, Taipei · Chang Gung Memorial Hospital, Linkou Branch, Taoyuan
Registry updated 2026-11-04
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
China Medical University Hospital, Taichung · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · National Taiwan University Cancer Center (NTUCC), Taipei City
Registry updated 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
Taichung Veterans General Hospital, Taichung · China Medical University Hospital, Taichung · National Taiwan University Hospital, Taipei · Chang Gung Medical Foundation-Linkou Branch, Taoyuan
Registry updated 2026-10-27
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Trial Treatment · Phase 3 · AstraZeneca
Taipei · Taoyuan
Registry updated 2026-10-21
NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Trial Treatment · Phase 2 · Sanofi
Taichung
Registry updated 2026-10-15
NCT05730036
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Changhua Christian Hospital, Changhua · Hualien Tzu Chi Hospital, Hualien City · Kaohsiung Medical University Hospital, Kaohsiung City · Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Wanfang Hospital, Taipei · National Taiwan University Hospital, Taipei · Tri-Service General Hospital, Taipei · Chang Gung Memorial Hospital, Linkou Branch, Taoyuan
Registry updated 2026-10-07
NCT07391657
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Trial Treatment · Phase 3 · AstraZeneca
Taipei
Registry updated 2026-09-29
NCT07518186
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Chang Kung Memorial Hospital, Kaohsiung City · China Medical University Hospital, Taichung · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei
Registry updated 2026-09-25
NCT07210047
Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
Trial Treatment · Phase 1/2 · HuniLife Biotechnology, Inc.
Far Eastern Memorial Hospital, Taipei
Registry updated 2026-09-18
NCT05020236
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Trial Treatment · Phase 3 · Pfizer
Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung City · China Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-08-24
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Trial Treatment · Phase 3 · Pfizer
China Medical University Hospital, Taichung · Taichung Veterans General Hospital, Taichung
Registry updated 2026-08-24
NCT05714839
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Changhua · Kaohsiung City · Taipei
Registry updated 2026-08-19
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Taipei Municipal Wan Fang Hospital, Taipei
Registry updated 2026-08-18
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Trial Treatment · Phase 3 · AstraZeneca
Taipei · Taoyuan
Registry updated 2026-08-14
NCT07751783
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
Trial Treatment · Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung
Registry updated 2026-08-07
NCT07728188
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · AbbVie
Kaohsiung Chang Gung Memorial Hospital /ID# 282970, Kaohsiung City
Registry updated 2026-07-27
NCT06057402
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Trial Treatment · Phase 4 · Pfizer
National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-07-01
NCT06679101
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Trial Treatment · Phase 3 · GlaxoSmithKline
Kaohsiung City · Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-04-22
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-03-24

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error